MedTrace
MedTrace Pharma innovates medical imaging to help doctors diagnose patients faster and more accurately, with lower costs, while boosting patient comfort.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
* | €18.2m Valuation: €150m 425.3x EV/Revenue -24.4x EV/EBITDA | Series C | |
| Total Funding | 000k | ||
| EUR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | - | - | 43 % | 21 % | (12 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | - | - | (1600 %) | (2105 %) | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | - | - | (1167 %) | (1689 %) | (571 %) | (658 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | - | - | - | - | 1374 % | - | - |
Source: Company filings or news article
Related Content
Developer of medical devices designed to offer novel safety features to revolutionize blood flow imaging in PET. The company's devices automate bedside production and infusion of radioactive water in the PET scanner suite and consist of a remotely operated unit producing the radioactive water to innovate PET diagnostic imaging by transforming blood flow quantification, enabling physicians to get a platform that assists them to focus on heart-study applications, brain and tumor vascularization, and diabetes studies.
Keywords: Pharmaceuticals and Biotechnology, Blood Flow Imaging, Cardiac Imaging, Cardiac Imaging Software, Cardiac Imaging Technology, Disease Diagnostics, Imaging Technology, Oncology Diagnostic Test, Oncology Imaging, Radiopharmaceutical Diagnostics, Radiopharmaceutical Research.